HELIX BIOPHARMA CORP (HBP.CA) Stock Income Statement
Canada - Toronto Stock Exchange - TSX:HBP - CA4229102088 - Common Stock
2.4 CAD
0 (0%)
| TTM (2025-10-31) | 2025 (2025-7-31) | 2024 (2024-7-31) | 2023 (2023-7-31) | 2022 (2022-7-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Minority Interest Expense | N/A | N/A | N/A | N/A | N/A | |||
| Operating Expenses | 4.73M | 5.40M | 9.24M | 6.33M | 6.04M | |||
| Research and Development | 2.65M | 3.58M | 6.09M | 5.27M | 4.53M | |||
| Selling, General, and Administrative Expenses | 2.10M | 1.84M | 3.26M | 1.04M | 1.50M | |||
| Operating Income | -4.73M | -5.40M | -9.24M | -6.33M | -6.04M | |||
| Interest Income/Expense | -194.00K | -130.00K | -25.00K | 31.00K | -23.00K | |||
| Other Income/Expense | 37.00K | 305.00K | N/A | 0.00 | -500.00K | |||
| Non Recurring Items | N/A | N/A | N/A | N/A | N/A | |||
| Income Before Taxes | -4.88M | -5.21M | -9.26M | -6.29M | -6.56M | |||
| Income Tax | N/A | N/A | N/A | N/A | N/A | |||
| Net Income | -4.88M | -5.21M | -9.26M | -6.29M | -6.56M | |||
| EBITDA | -4.72M | -5.39M | -9.22M | -6.31M | -6.03M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.08 | -0.09 | -0.21 | -0.16 | -0.22 | |||
| Statistics | ||||||||
All data in CAD